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Epicutaneous sensitization with protein allergens differentiates naı¨ve T cells
into not only Th2 but also Th17 cells, which may involve in the delayed
reactions in protein contact dermatitis
T Yuki, A Ogasawara, K Yokozeki, Y Takahashi and H Sakaguchi Safety Science Research
Laboratories, Kao corporation, Haga-Gun, Japan
Protein contact dermatitis (PCD) is caused by proteins. The patients may show positive im-
mediate or delayed reactions in skin prick, scratch or patch test, or the skin tests may remain
negative. Specific IgE is obviously crucial in most reactions, however, the exact mechanisms
remains unclear. To address these issues, we investigated mice sensitized by papain enzyme
as a protein allergen. Mice were sensitized by 24hrs exposure to papain twice a week for one
month. The draining lymph node cells were then isolated and re-stimulated by papain. ELISA
and FACS analyses of the cytokines synthesized in lymph node cells revealed that CD4+ IL4+
T (Th2) and CD4+ IL17+ T (Th17) cells were differentiated in the draining lymph nodes of the
mice sensitized by papain. However, CD4+ IFN-gamma+ T cells (Th1) were not detected. The
sensitized mice were elicited by applying papain onto the ear to address the role of Th2 and
Th17 cells differentiated in the papain-sensitized mice, and the allergic reactions in the ear
were examined. Real-time PCR analyses revealed that IL-17 mRNA of Th17 marker was up-
regulated in a time-dependent manner; however, IL-4 mRNA of Th2 maker was not detected
at any time points. These phenomena were confirmed by immunofluorescent microscopy
using a specific antibody for IL-17, suggesting that Th17, but not Th2, migrated into the ear
after the elicitation. Additionally, the papain-sensitized mice possessed papain-specific IgE,
and mast cell degranulation was observed after the elicitation. These findings reveal for the
first time that the sensitization of papain enzyme differentiates naı¨ve T cells into not only Th2
but also Th17 cells as effector T cells contributing to the allergic reactions. The generated Th2
produces IL-4 and is involved in IgE syntheses in the draining lymph nodes. Conversely, the
generated Th17 cells migrate to the skin and produce IL-17 after elicitation, which may
involve in the delayed reactions of PCD.074
+Interleukin 31 production is associated with Histamine H4 receptor of CLA
+CD45RO T cell
C Bang, J Song, Y Song, J Lee, Y Park and J Lee Dermatology, Seoul St. Mary’s Hospital, Seoul,
Korea (the Republic of)
Interleukin-31 (IL-31) is a recently-discovered Th2-cell-derived cytokine which can induce
severe pruritus and skin lesions such as atopic dermatitis (AD). IL-31 mRNA and protein
expressions are largely restricted to CD4+ T cells, particularly CD45RO+ (memory) CLA+ T
cells. However, the mechanism of IL-31 production in these cells is not fully recognized yet.
Histamine-4-receptor (H4R) is a recently described type of histamine receptor upregulated
under Th2 conditions, and HR4 stimulation leads to the induction of IL-31 in vitro. However,
the mechanism and association between IL-31 and H4R in human has not been reported. The
purpose of the present study is to evaluate the hypothesis that H4R+ CLA+ CD45RO+ T cells
produce IL-31 predominantly. To investigate that H4R+ cells produce IL-31, immunofluo-
rescence studies were performed on punch biopsy specimens of 5 AD, 3 prurigo nodularis
and 3 healthy controls. In addition, blood samples were collected from 12 AD patients and
healthy controls. The H4R+ CLA+ CD45RO+ T cells and the other cells were sorted by
fluorescence-activated cell sorting (FACS). These sorted cells were stimulated with 4-meth-
ylhistamine and the level of IL-31 in the culture supernatant were measured by enzyme-
linked immunosorbent assay. Under high-power field, the IL-31+ H4R+ colocalized cell
counts in biopsy specimens were 12.9  9.2, 6.7  6.0 and 0.0  0.0 in AD, prurigo nod-
ularis, and control samples, respectively (p<0.01). The result of FACS showed that the pro-
portion of H4R+ CLA+ CD45RO+ T cells were 31.5  9.6% and 23.1  5.2% in AD and
healthy control, respectively. In AD patients, these cells showed 2.3-fold higher production of
IL-31 compared to healthy control (p<0.05). According to our study, H4R+ CLA+ CD45RO+ T
cells are a major source of IL-31, and this subset may be targets for the treatment of IL-31
induced pruritus.075
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Mucous membrane pemphigoid (MMP) is characterized by autoantibodies against the
dermal-epidermal-junction and a mucosal disease predominating over skin involvement. As
the treatment of MMP patients still relies on high-dose corticosteroids, there is an unmet need
for new and more specific therapies. Here, we made use of a recently established experi-
mental model that recapitulated major clinical and immunopathological characteristics of
human MMP by the injection of IgG against the murine alpha3 chain of laminin 332
(Lam332) into adult mice. In a prophylactic approach, the specific PDE4 inhibitor roflumilast
(ROF) led in 2 independent, blinded experiments, to the reduction of oral lesions compared to
vehicle-treated mice as quantified by endoscopy (p¼0.029). In contrast, an increase in skin
lesions was observed in ROF-treated mice (p<0.0001). In a quasi-therapeutic approach, i.e.
when ROF/vehicle was not used until mice had developed first skin lesions, ROF-treated mice
showed significantly less oral lesions compared to vehicle-treated mice, while skin lesions did
not differ. To investigate the discrepant effect of ROF on oral and skin lesions, a transcriptome
analysis of both tissues in ROF- and vehicle-treated anti-Lam332 MMP mice as well as mice
injected with normal rabbit IgG was performed. An up-regulation of IL-6 and an impact of
CXCL2 were found by Gene Set Enrichment and STRING analysis, respectively, in both the
skin and buccal mucosa of vehicle-treated mice. The subsequent incubation of murine ker-
atinocytes with anti-mLam332 IgG resulted in a dose-dependent release of IL-6 and CXCL2,
which was inhibited by the addition of ROF. Our data propose IL-6 and CXCL2 as relevant
pathogenic factors in MMP and suggest PDE4 inhibition as potential novel treatment options
for MMP patients with severe oral lesions.076
Skin tissue resident memory T cells in HIV infection
S Saluzzo, J Strobl, B Reininger, R Dingelmaier-Hovorka, A Rieger, V Touzeau-Roemer, G
Stingl and G Stary Dermatology, Medical University of Vienna, Vienns, Austria
There is still no cure for HIV, as the virus can survive in quiescent CD4+ subsets and rebound
as soon as combined antiretroviral treatment (cART) is interrupted. Current cART is so
effective in stopping viral replication and allowing immune reconstitution of the CD4 T cell
pool, that people living with HIV (PLWH) have a life expectancy similar to the healthy
population. However, new challenges in HIV management are emerging, in particular the
increased risk for developing non-HIV-related cancers, like the human papilloma virus (HPV)
induced anal cancer. Tissue resident memory T cells (TRM) are a critical component of our
immune defence and play accumulating roles in tissue homeostasis and cancer surveillance.
We therefore sought to investigate skin TRM in PLWH. We collected skin biopsy and pe-
ripheral blood mononuclear cells (PBMCs) from individuals during the acute and chronic
phase of HIV infection for the characterization of skin immune cells by Tissue-FACS software,
flow cytometry, cell sorting, DNA and RNA analysis. Our preliminary results show that the
CD4 TRM numbers are strongly reduced in the skin of PLWH, despite of immune-reconsti-
tution of the blood CD4+T cell pool upon begin of cART. Low skin CD4+ TRM numbers do
not show correlation with the circulatory CD4+T cells, but rather with the nadir, i.e. the
lowest blood CD4+T cell number the history of the patients. These preliminary data suggest
that the skin CD4+ TRM are targeted by HIV and never reconstituted, despite initiation of
cART and immune reconstitution of the recirculating CD4+ cell pool. In further analysis, we
will follow the skin CD4+ TRM cell numbers at diagnosis and 1 year after therapy begin. We
will also analyse the skin CD4 TRM cells in the mucosal tissue of PLWH which underwent
biopsies for HPV dysplasia screening. Our study will shed light on the mechanism of skin and
mucosa immune surveillance in chronic HIV infection and might help identifying the cause of
increased HPV related dysplasia in this risk population.077
Type I immunity induces a senescence-like growth arrest in malaria parasites
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Type I immunity kills and contains plasmodium species in mammalians. However, malaria
tends to recur, showing that the natural type I immune response strongly reduces the path-
ogens but fails to eradicate them. Analyzing the effect of type I immunity on plasmodium-
infected hepatocytes, we confirmed that indeed IFN (interferon)-g strongly reduces parasite
number. Surprisingly, we also found that IFN-g induces in addition a senescence-like growth
arrest in the remaining plasmodium parasites. One day of treatment with IFN-g caused a
stable growth-arrest over 14 days in surviving Plasmodium (P.) falciparum liver stages. IFN-g
induced small non-proliferating plasmodium forms in human, monkey and mouse hepato-
cytes. Atovaquone treatment killed the large majority of the remaining parasites confirming
that these small forms are alive. In vitro data showed that mammalian p21 can interact with
parasite cyclin-dependent kinases (CDK) PFMRK, PFPK5 and PFPK6. Inhibition of these CDKs
with Artemisinin severely impairs the growth of P.falciparum, without killing the parasites.
Therefore, we asked whether IFN-g and plasmodium parasites induce p21 in mammalian
hepatocytes and whether mammalian p21 can arrest P.falciparum in vivo. Liver-infection
with plasmodium parasites leads to an interferon-response and induced p21 but not p16
protein levels inside primary hepatocytes. The p21 protein was further enhanced by treatment
with IFN-g and tumor necrosis factor. Most importantly, p210/0 hepatocytes had a major
defect in containing malaria parasites in vitro. In consequence, infection of p210/0 mice had a
major defect in controlling the onset and the extent parasitemia. Hence, type I immunity did
not only kill malaria parasites but induced a p21-dependent senescence-like growth arrest in
the remaining plasmodium stages. This IFN-g induced senescence-like growth arrest signif-
icantly contributed to the containment of the disease.078
IgE in skin and serum of nonbullous and bullous pemphigoid patients
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Nonbullous pemphigoid (NBP) is a pemphigoid variant, in which for unknown reason pa-
tients do not develop blisters. In bullous pemphigoid (BP) accumulating evidence suggests a
role for IgE in disease pathogenesis, and possibly in blister formation. This study assessed the
presence of IgE in serum and skin of BP and NBP, using enzyme linked immunosorbent assay
(ELISA) and immunofluorescence techniques. We included 67 NBPand 50 BP serum samples,
and control sera of 25 pemphigus patients, and 25 elderly patients with pruritus. Total IgE was
elevated in 60% and 63% of BP and NBP, and in 20% and 60% of pemphigus and elderly
controls. IgE ELISAs were more frequently positive in BP than in NBP (NC16A 18% vs. 9%,
p¼0.139; BP230 34% vs. 22%, p¼0.149). IgE optical density values were significantly higher
in BP compared with NBP (p¼0.000). Surprisingly, elderly controls had IgE antibodies to
NC16A and BP230 in 8% and 20%, while all pemphigus controls were negative. Increased
total IgE correlated with positive anti-NC16A IgE ELISA in BP (p¼0.007), and positive anti-
BP230 IgE ELISA in NBP (p¼0.000). In elderly controls specific and total IgE did not correlate.
Skin biopsies of 14 BP and 14 NBP patients with highest anti-NC16A IgE ELISA titers were
stained for IgE for direct immunofluorescence microscopy. Four biopsies (14%; 2 NBP, 2 BP)
showed linear IgE along the basement membrane zone, while IgE was mostly bound to the
surface of dermal cells (71% NBP, 86% BP). In conclusion, IgE was present in serum and skin
of both NBP and BP patients, suggesting a supportive role of IgE instead of being a key
mediator of blister formation in pemphigoid.www.jidonline.org S227
